CAS: 6151-30-0; Quinacrine 2Hcl 2H2O

该化合物是属于类丙烯衍生物的化学化合物,主要以其用作抗疟剂而著称,还被用于各种研究应用,特别是分子生物学和遗传学领域的研究应用;该化合物看起来像一种黄色晶状粉,在水中可溶解,有助于将其用于水溶的生物鉴定;二氯化氢二酸物的浮质特性,使其在显微镜和染色技术中有用;其行动机制涉及DNA的相互切换,这可能导致抑制核酸合成;此外,已研究该物质对某些细胞过程的潜在影响,并在除疟疾治疗外的各种治疗应用中显示出希望;但是,由于潜在的副作用和毒性,其使用须接受监管审查,因此需要在研究和临床环境中仔细处理和考虑.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:WO-2017082924-A1
    优先权日:2015-11-13
    标题 :Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
    发明人:BURKE TERRENCE R JR; HYMEL DAVID
    权利人:THE US SECRETARY DEPT OF HEALTH & HUMAN SERVICES
    摘要:The description provides novel compounds that may serve as anticancer therapeutics. The compounds of the description bind to polo-like kinases through the polo-box domain. The peptide derivatives of the description have achieved improved efficacy in biochemical assays against Plk1. The description also provides methods of use, methods of preparation, compositions, and kits thereof. Further, the description provides a novel method of design and/or synthesis of phosphoryl-derived peptide derivatives useful as therapeutic agents.

    专利号:US-10905769-B2
    优先权日:2015-11-13
    标 题:Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use
    发明人:BURKE JR TERRENCE R; HYMEL DAVID T; TSUJI KOHEI
    权利人:THE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES
    摘要:The description provides novel compounds that may serve as anticancer therapeutics. The compounds of the description bind to polo-like kinases through the polo-box domain. The peptide derivatives of the description have achieved improved efficacy in biochemical assays against Plk1. Exemplary compounds of the description include macrocyclic peptidomimetics with high affinity and selectivity for polo-like kinases, which may provide the basis for a new genre of anticancer therapeutics. Other exemplary compounds of the description include bi-valent compounds with that bind to polo-like kinases through both kinase domain and polo-box domain simultaneously by incorporating additional moieties that target Plk1 kinase domain, which significantly enhances affinitity relative and may provide the basis for a new genre of anticancer therapeutics. The description also provides methods of use, methods of preparation, compositions, and kits thereof. Further, the description provides a novel method of design and/or synthesis of phosphoryl-derived peptide derivatives useful as therapeutic agents.

    专利号:US-7393954-B2
    优先权日:2002-12-12
    标题:Process for the production of pentostatin aglycone and pentostatin
    发明人:NADJI SOURENA; SMOOT JAMES; SAMPATH UMASHANKER
    权利人:RELIABLE BIOPHARMACEUTICAL COR
    摘要:A novel, scaleable and improved process for preparing pentostatin and its analogs is disclosed. The method comprises the diastereospecific synthesis of the nucleobase from commercially available L-Dialkyl tartarates.

    专利号:US-7582748-B2
    优先权日:2003-03-20
    标题:Methods of manufacture of 2′-deoxy-β-L-nucleosides
    发明人:RABI JAIME A
    权利人:MICROBIOL QUIMICA FARMACEUTICA
    摘要:The present invention relates to the synthesis of 2′-deoxy-β-L-thymidine, 2′-deoxy-β-L-uridine and 2′-deoxy-β-L-cytidine, and their derivatives, such as the 3′-O-acyl or 3′,5′-O-diacyl prodrugs, including the 3′-O-L-aminoacyl and 3′,5′-O-L-diaminoacyl prodrugs, and particularly the 3′-O-L-valinyl and 3′,5′-O-L-divalinyl prodrugs.

    专利号:US-2014243404-A1
    优先权日:2010-09-14
    标题 :Unique halogen-induced cyclizations, reagents therefor, and compounds produced thereby
    发明人:SNYDER SCOTT ALAN; TREITLER DANIEL S; BRUCKS ALEXANDRIA P; GOLLNER ANDREAS; CHIRIAC MARIA I; WRIGHT NATHAN E; PFLUEGER JASON J; BREAZZANO STEVEN P
    权利人:SNYDER SCOTT ALAN; TREITLER DANIEL S; BRUCKS ALEXANDRIA P; GOLLNER ANDREAS; CHIRIAC MARIA I; WRIGHT NATHAN E; PFLUEGER JASON J; BREAZZANO STEVEN P; UNIV COLUMBIA
    摘要:This disclosure is related to halonium compounds useful for cyclization of polyenes, alkenoic acids, and alkenyl alkyl ethers, and halogenation of aromatic compounds. The synthesis of such halonium compounds, compounds made using such halonium compounds, and synthesis of natural compounds, including decalins, using the halonium compounds is also disclosed. A representative halonium compound of the disclosure is:

    专利号:US-5688992-A
    优先权日:1995-03-31
    标题 :O-malonyltryrosyl compounds, O-malonyltryrosyl compound-containing peptides, and use thereof
    发明人:BURKE JR TERRENCE R; YE BIN; AKAMATSU MIKI; KOLE HEMANTA K; YAN XINJIAN; ROLLER PETER R
    权利人:US HEALTH
    摘要:The present invention relates to non-phosphorus containing O-malonyltryrosyl compounds, derivatives thereof, uses of the O-malonyltryrosyl compounds in the synthesis of peptides, and O-malonyltryrosyl compound-containing peptides. The O-malonyltyrosyl malonyltyrosyl compounds and O-malonyltryrosyl compound-containing peptides of the present invention are uniquely stable to phosphotases, capable of crossing cell membranes, suitable for application to peptide synthesis of O-malonyltryrosyl compound-containing peptides, and amenable to prodrag defivatization for delivery into cells. The present invention also provides for O-malonyltryrosyl compound-containing peptides which exhibit inhibitory potency against binding interactions of receptor domains with phosphotyrosyl-containing peptide ligands.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bhattacharyya S. Quinacrine sterilization (QS): the ethical issues. Int J Gynaecol Obstet. 2003 Oct;83 Suppl
    2:S13-21. Review. Review. Review. Japanese. Review. Review.

    合成参考文献


    摘要:Toxicology and Applied Pharmacology., 44(225), 1978 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知